Psoriasis, a genetic skin condition affecting nearly 300,000 individuals in Sweden, not only manifests on the skin but also triggers joint inflammation. Interestingly, research indicates that individuals with psoriasis are more prone to chronic inflammatory bowel diseases like Crohn’s disease compared to the general population.
Maria Lampinen, a researcher at Uppsala University, sheds light on this intriguing connection by stating, “People with psoriasis often experience more gastrointestinal issues than the average person. Our study reveals that individuals with psoriasis frequently exhibit hidden inflammation in their small intestines, increasing their risk of developing leaky gut syndrome.”
In a groundbreaking study involving 18 psoriasis patients and 15 healthy controls without gastrointestinal conditions, samples were collected from both the small and large intestines for analysis. The researchers focused on examining various immune cells present in the mucous membrane.
“It was discovered that individuals with psoriasis had elevated levels of specific immune cells in their small intestine, displaying indications of pro-inflammatory behavior.”
What makes this finding even more intriguing is the correlation between these immune cells found in skin flare-ups of psoriasis patients and those present in their gut. This suggests a potential interplay between skin inflammation and gut health.
The intestinal mucosa typically functions as a protective barrier while allowing essential nutrients and water to pass through. However, in autoimmune conditions, this barrier may become compromised, resulting in leaky gut syndrome. This condition enables bacteria and harmful substances to escape through the intestinal barrier into the bloodstream, triggering widespread inflammation.
Surprisingly, half of the psoriasis patients examined exhibited increased permeability in their intestinal barriers or leaky gut. These same individuals reported higher incidences of gastrointestinal symptoms such as bloating and abdominal pain compared to those with normal intestinal barriers. Additionally, they displayed heightened levels of inflammatory compounds within their intestines.
Lampinen emphasizes the significance of these findings by stating, “Despite having mild skin manifestations and no visible signs of intestinal inflammation during gastroscopy examinations – our study participants showcased distinct alterations in their small intestines when compared to healthy counterparts.”
The implications extend beyond understanding gastrointestinal issues among psoriasis patients; they could potentially pave the way for improved treatment strategies aimed at addressing these interconnected concerns effectively.
Following publication in Psoriasisförbundet (the Swedish Psoriasis Association) member magazine about this research breakthrough led by Lampinen’s team , numerous individuals reached out seeking further insights into how gut health influences skin conditions like psoriasis.
“They wanted deeper insights into how gut health impacts skin issues as they noticed a strong correlation between symptoms affecting both areas.”
This growing body of research not only underscores the importance of recognizing and addressing gastrointestinal problems among psoriasis patients but also highlights how enhanced knowledge can guide healthcare providers towards more comprehensive care approaches tailored to address both skin and gut health intricately.
Funded by organizations like Psoriasis Association’s managed funds & Hudfonden (the Skin Foundation), studies like these serve as vital stepping stones towards holistic management strategies focusing on alleviating symptoms across various facets affected by psoriatic conditions
Leave feedback about this